COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

COVID-19 Briefings

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

CMS Releases Answers to Frequently Asked Questions About Nursing Home SARS-CoV-2 Antigen Test Distribution

CMS maze of rules and regulations
Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on whatsapp
Share on email
Share on facebook
Share on twitter
Share on linkedin
Share on google
Share on whatsapp
Share on email

New guidelines clarify conditions and processes covering COVID-19 antigen test distribution to nursing homes.

The Centers for Medicare and Medicaid Services (CMS) released guidelines that outline the conditions and processes that will be used to distribute federally funded SARS-CoV-2 antigen tests to nursing homes across the US. These guidelines were released on August 5, 2020, in the form of a frequently asked questions (FAQ) document.

These CMS guidelines include 27 FAQs and detailed answers to each question. These questions address a variety of topics, including:

  • Who will be receiving antigen tests and instruments and how many per entity will be distributed;
  • How distributions will be prioritized and scheduled;
  • How training for these new devices will be provided;
  • The plans for future distributions;
  • Safety precautions that should be taken when performing these tests;
  • How the antigen tests function and their clinical significance;
  • The regulations and Clinical Laboratory Improvement Amendments (CLIA) requirements for providing SARS-CoV-2 antigen testing; and
  • Special, state-specific exemptions or requirements.

Clinical laboratories or test distributers wishing to learn more about the details regulating the distribution of SARS-CoV-2 antigen tests should visit the CMS FAQs here.

Regulatory Resource:

Frequently Asked Questions: COVID-19 Testing at Skilled Nursing Facilities/ Nursing Homes


Helping Your Lab Stay Afloat During Challenging Times

Dear Colleague,

Robert L. MichelIn these challenging times for our colleagues in clinical laboratories, pathology practices and hospital administration, The Dark Intelligence Group (TDIG) — through generous grants from our partners — is bringing you the COVID-19 STAT Intelligence Briefings.

We’ve added analysts, writers and skilled editors to the COVID-19 STAT team to uncover, analyze, and immediately report to you what’s happening with the SARS-CoV-2 pandemic, packaged with the insights you need to deliver quality testing for patient care and keep your lab’s financial ship afloat. As part of our mission, we are also bringing you real-time data from our partners around testing that you will not find anywhere else.

Please let me know how we can better improve this service to fit your needs. If you would like to offer a grant to keep our mission going with this site, please contact me at


Robert L. Michel
President, Founder
The Dark Intelligence Group